Mechanisms of Nitrite Mediated Hepatic Preconditioning: Role of the Mitochondria
Mechanisms of Nitrite Mediated Hepatic Preconditioning: Role of the Mitochondria
批准号:
7344816
负责人:
John Winter Calvert
金额:
$2.85万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2008-06-30
关键词:
AttenuatedBackBiologicalCalciumClinicalComplexCyclic AMP-Dependent Protein KinasesCytochromesCytosolDataEvaluationFailureGenerationsGraphHepaticHourInjuryInterventionIschemiaIschemic PreconditioningLiverLiver DysfunctionMediatingMembrane PotentialsMitochondriaMitochondrial MatrixMolecularMorbidity - disease rateNitric OxideNitritesOperative Surgical ProceduresOrgan TransplantationOrgan failureOutcomeOxidation-ReductionPatientsPhysiological reperfusionPotassium ChannelProductionRecoveryReperfusion InjuryReperfusion TherapyResearchRespirationRoleSignal TransductionStructureTestingTherapeuticTissuesbaseclinical applicationimprovedliver transplantationmitochondrial membranemortalitypreconditioninguptake
中文摘要
肝脏缺血/再灌注(I/R)导致的肝功能障碍或衰竭是发病率的主要原因
以及接受过肝移植手术的患者的死亡率。目前,没有治疗方法
战略的存在,捐赠者之间不断扩大的供需缺口迫使
考虑身体或脂肪变性图形,它们非常容易受到I/R的影响。
可能需要不止一个水平来允许细胞和器官衰竭的恢复,最
最近几年探索的针对I/R损伤的有前途的保护策略是预适应。因此,
模拟这些影响的缺血预适应或药物干预可能具有最大的作用
改善肝移植和肝外科临床结果的潜力。最近,亚硝酸盐通过
一氧化氮(NO)的产生已被证明在肝脏I/R的环境中具有细胞保护作用,
提示亚硝酸盐可能作为NO的生物储备库,在组织中具有重要的功能
对缺血损伤的保护。此外,我们实验室的初步数据表明,政府
在I/R前24小时服用亚硝酸盐可保护肝脏免受损伤。此外,亚硝酸盐预适应被发现可以
减轻L/再灌注对线粒体呼吸的抑制作用。因此,这项提案的目标是
是深入研究线粒体在亚硝酸盐介导的肝脏预适应中的作用
假设亚硝酸盐预适应保护线粒体的结构和功能
在肝脏I/R后,从而减轻肝细胞损伤。建议进行这项研究的理由是
明确亚硝酸盐预适应的机制可为临床推广应用提供依据。
适用于面临肝移植或肝脏手术的患者。因此,我们计划测试我们的中心假设
并通过追求两个具体目标来实现拟议研究的目标。具体目标1将进一步
通过评估线粒体对线粒体的保护作用,扩展我们的初步数据
线粒体基质体积、线粒体膜电位、线粒体钙摄取、
不同复合体的线粒体呼吸、ATP产生、氧化还原电位、ROS产生和
最后,细胞色素C从线粒体释放到胞浆中。《特定目标2》将迈出一步
通过检测线粒体的作用探讨亚硝酸盐预适应的信号机制
K+通道。我们认为,亚硝酸盐通过转化为一氧化氮,保护线粒体免受
介导线粒体K+通道mKATP和mKCa开放的继发性I/R损伤
PKC和PKA的分子信号转导。
英文摘要
Liver dysfunction or failure, as a result of hepatic ischemia/reperfusion (I/R), is a leading cause of morbidity
and mortality for patients who have undergone liver transplantation surgery. Currently, no therapeutic
strategy exists and the ever growing gap between supply and demand for donors has forced the
considertation of cadaveric or steatotic graphs, which are very susceptible to I/R. Because intervention on
more than one level is likely needed to allow for the recovery of cellular and organ failure, the most
promising protective strategy against I/R injury explored in the last few years is preconditioning. Therefore,
ischemic preconditioning or pharmacological interventions that mimic these effects may have the greatest
potential to improve clinical outcome in liver transplantation and liver surgery. Recently, nitrite through the
generation of nitric oxide (NO) has been shown to have cytoprotective effects in the setting of hepaticI/R,
suggesting that nitrite may serve as a biological storage reserve of NO subsurving a critical function in tissue
protection from ischemic injury. Furthermore, preliminary data from our lab indicates that the administration
of nitrite 24 hours prior to I/R protects the liver against injury. Moreover, nitrite preconditioning was found to
attenuate the l/R-induced suppression of mitochondrial respiration. Therefore, the objective of this proposal
is to delve into the role of the mitochondria in nitrite mediated hepatic preconditioning with the central
hypothesis being that nitrite preconditioning preserves the structure and function of the mitochondria
following hepatic I/R, thereby attenuating hepatocellular injury. The rationale for the proposed research is
that identifying the mechanisms of nitrite preconditioning may provide a basis for extending the clinical
application to patients facing liver transplantation or liver surgery. So, we plan to test our central hypothesis
and accomplish the objective of the proposed study by pursuing two specific aims. Specific aim 1 will further
expand on our preliminary data by exploring the-protectionof the mitochondria through the evaluation of
mitochondrial matrix volume, mitochondrial membrane potential, mitochondiral uptake of calcium,
mitochondrial respiration of the different complexes, ATP production, redox potential, ROS production, and
finally the release of cytochrome C from the mitochondria into the cytosol. Specific aim 2 will take a step
back and explore the signaling mechanisms of nitrite preconditioning by examining the role of mitochondrial
K+ channels. We believe that nitrite, through its conversion to NO, protects the mitochondria from a
subsequent I/R injury by mediating the opening of the mitochondrial K+ channels, mKATP and mKCa, via
the molecular signaling of PKC and PKA, respectively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of CSE-Derived Hydrogen Sulfide in the Heart
-
批准号:10659832
-
项目类别:
-
资助金额:$52.15万
-
财政年份:2023
-
负责人:John Winter Calvert
-
依托单位:
Novel Insights into Ischemic-Induced Cardiac Remodeling
-
批准号:9934694
-
项目类别:
-
资助金额:$1.82万
-
财政年份:2018
-
负责人:John Winter Calvert
-
依托单位:
Novel Insights into Ischemic-Induced Cardiac Remodeling
-
批准号:10063890
-
项目类别:
-
资助金额:$47.86万
-
财政年份:2018
-
负责人:John Winter Calvert
-
依托单位:
Targeting the orphan nuclear receptor LRH-1 with small molecules
-
批准号:9403854
-
项目类别:
-
资助金额:$49.0万
-
财政年份:2017
-
负责人:John Winter Calvert
-
依托单位:
Targeting the orphan nuclear receptor LRH-1 with small molecules
-
批准号:10660545
-
项目类别:
-
资助金额:$56.93万
-
财政年份:2017
-
负责人:John Winter Calvert
-
依托单位:
Targeting the orphan nuclear receptor LRH-1 with small molecules
-
批准号:10681892
-
项目类别:
-
资助金额:$15.4万
-
财政年份:2017
-
负责人:John Winter Calvert
-
依托单位:
Hydrogen sulfide attenuates heart failure through Nrf2-mediated signaling
-
批准号:8383492
-
项目类别:
-
资助金额:$36.52万
-
财政年份:2010
-
负责人:John Winter Calvert
-
依托单位:
Hydrogen sulfide attenuates heart failure through Nrf2-mediated signaling
-
批准号:7767448
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2010
-
负责人:John Winter Calvert
-
依托单位:
Hydrogen sulfide attenuates heart failure through Nrf2-mediated signaling
-
批准号:8011451
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2010
-
负责人:John Winter Calvert
-
依托单位:
Hydrogen sulfide attenuates heart failure through Nrf2-mediated signaling
-
批准号:8197419
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2010
-
负责人:John Winter Calvert
-
依托单位:
Hydrogen sulfide attenuates heart failure through Nrf2-mediated signaling
-
批准号:8586340
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2010
-
负责人:John Winter Calvert
-
依托单位:
Mechanisms of Nitrite Mediated Hepatic Preconditioning: Role of the Mitochondria
-
批准号:7219324
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2006
-
负责人:John Winter Calvert
-
依托单位:
国内基金
海外基金
患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
-
批准号:2026JJ81464
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:叶婷
-
依托单位:
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
-
批准号:2024KP61
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:余丹
-
依托单位:
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
-
批准号:51307073
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2013
-
负责人:郭兴龙
-
依托单位: